Dear customers,

we have started to provide the documents for our products in an electronic format. These are the Instructions for Use (IFU), the Safety Data Sheets (SDS) and the Certificate of Analysis (CoA). For batches placed on the market after 01 January 2023, you can find our documents on the eIFU portal https://eifu.r-biopharm.com.

RIDA®GENE Flu & SARS-CoV-2

Intended use:For in vitro diagnostic use. The RIDA®GENE Flu & SARS-CoV-2 test, performed on the LightCycler® 480II real-time PCR instrument, is a multiplex real-time RT-PCR for the direct [...]

RIDA®GENE SARS-CoV-2

Intended use:For in vitro diagnostic use. The RIDA®GENE SARS-CoV-2 test, which will be performed on the Roche LightCycler® 480II, is a multiplex real-time RT-PCR for the direct qualitative [...]

RIDA®GENE MRSA

Intended use:For in vitro diagnostic use. The RIDA®GENE MRSA test, performed on the Roche LightCycler® 480 II, is a multiplex real-time PCR for the direct qualitative detection of [...]

RIDA®GENE CD Toxin A/B

Intended use:For in vitro diagnostic use. RIDA®GENE CD Toxin A/B is a real-time PCR for the direct, qualitative detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) genes from [...]

RIDA®GENE EHEC/EPEC

Intended use:For in vitro diagnostic use. RIDA®GENE EHEC/EPEC is a multiplex real-time PCR for the direct, qualitative detection and differentiation of genes encoding the virulence-factors of [...]

RIDA®GENE EAEC

Intended use:For in vitro diagnostic use. RIDA®GENE EAEC is a multiplex real-time PCR for the direct, qualitative detection of enteroaggregative E. coli (EAEC) in human stool samples. RIDA®GENE [...]

page  1  of  9